Volume 11, Issue 11 e1429
Corrigendum
Open Access

Memory stem T cells modified with a redesigned CD30-chimeric antigen receptor show an enhanced antitumor effect in Hodgkin lymphoma

First published: 03 November 2022

Carmen Alvarez-Fernández, Laura Escribá-Garcia, Ana Carolina Caballero, Eva Escudero-López, Cristina Ujaldón-Miró, Rosanna Montserrat-Torres, Paula Pujol-Fernández, Jorge Sierra & Javier Briones

Clinical & Translational Immunology 2022; 11: e1429.

Correction to: Clin Trans Immunol 2021; 10: e1268. https://doi.org.10.1002/cti2.1268. Published online 29 April 2021.

Ana Carolina Caballero's affiliation has been corrected. The complete affiliation is as follows:

4Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain.

The authors apologise for this error.

    The full text of this article hosted at iucr.org is unavailable due to technical difficulties.